| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8785848 | Cancer Treatment Reviews | 2018 | 25 Pages |
Abstract
Why do AYA patients have worse outcomes? The observation is that the reason is multifactorial with path to diagnosis, unique cancer biology, uncertainty of treatment protocol, compliance issues and poor recruitment to clinical trials all playing a part. In this review we will discuss the unique challenges faced by healthcare professionals when managing AYA patients who are commonly and accurately described as being in an 'interface' position.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Nicola Hughes, Dan Stark,